Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Supplemental Material
ajp_168_10_1066_01.pdf (44 KB)
ajp_168_10_1066_02.pdf (12 KB)
ajp_168_10_1066_03.pdf (9 KB)
The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
×From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
From the Departments of Psychiatry and Neurology, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, Piscataway, N.J.; and Merck and Co., Whitehouse Station, N.J.
ajp_168_10_1066_01.pdf (44 KB)
ajp_168_10_1066_02.pdf (12 KB)
ajp_168_10_1066_03.pdf (9 KB)